REVIVE-IT heart failure study resumes after safety modificationHealthCanal.comANN ARBOR, Mich. — The University of Michigan Health System received approval from the Food and Drug Administration (FDA) on March 12 to resume the REVIVE-IT (Randomized Eva…
Delhi scientists trying to grow liver in lab – Times of India
Delhi scientists trying to grow liver in labTimes of IndiaNEW DELHI: You may have heard of kidney dialysis but did you know that even the liver can be flushed of its toxins using a similar method? At the Institute of Liver and Biliary Sciences in New D…
City scientists trying to grow liver in lab – Times of India
City scientists trying to grow liver in labTimes of IndiaNEW DELHI: You may have heard of kidney dialysis but did you know that even the liver can be flushed of its toxins using a similar method? At the Institute of Liver and Biliary Sciences in New De…
A guide through complexity of India's medical care – The Asian Age
|
A guide through complexity of India’s medical care
The Asian Age “For instance, there are times when people write to us wanting a doctor for the liver and when we talk to them we realise there is a bigger problem that needs to be addressed which is alcoholism. So the conversation with the patient/attendant is … |
Actos Side Effects May Include Increased Risk of Chronic Kidney Disease – Injury Lawyer News
Actos Side Effects May Include Increased Risk of Chronic Kidney DiseaseInjury Lawyer NewsActos Side Effects May Include Risk of Chronic Kidney Disease New research suggests that an increased risk of chronic kidney disease may be among the many Actos si…
Six-minute walk test could help guide heart failure treatment – Medical Xpress
|
Six-minute walk test could help guide heart failure treatment
Medical Xpress (HealthDay)—Distance achieved in the six-minute walk test may be a practical measure of functional capacity that guides selection of therapy for patients with heart failure, according to research published online April 9 in the Journal of the American … |
UPDATE: Boston Scientific Reports FDA Approval for Latest Generation of Defib … – Benzinga
|
UPDATE: Boston Scientific Reports FDA Approval for Latest Generation of Defib …
Benzinga Boston Scientific Corporation (NYSE: BSX) has received FDA approval for its latest generation of defibrillators and heart failure devices designed to advance patient care. The newly approved devices include the DYNAGEN™ MINI and INOGEN™ MINI ICDs, … |
Boston Scientific Corp. (BSX) Reports FDA Approval of Latest Heart Failure … – StreetInsider.com (subscription)
Boston Scientific Corp. (BSX) Reports FDA Approval of Latest Heart Failure …StreetInsider.com (subscription)Boston Scientific Corporation (NYSE: BSX) has received FDA approval for its latest generation of defibrillators and heart failure devices desi…
Reining in cancer – The Hindu
Reining in cancerThe HinduGrim statistics present the deadly reality of the spread of cancer in India: one million new cases of different cancers are diagnosed every year in the country; an estimated 600,000 to 700,000 people were killed in 2012. The f…
Why We Run: finding peace within – WLBZ-TV
|
Why We Run: finding peace within
WLBZ-TV His father’s treatment included a stem cell transplant, two different trials at Dana-Farber, a medication dosage that cost $3,200 a day, and a case of pneumonia. Plus, there was the constant fear that the cancer would regain its strength. Fourteen … |